Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

The facility is the centrepiece of a 10-year agreement-in-principle between the biotech and the UK government – which has been rumoured to be on the cards ... of Moderna’s COVID-19 vaccine ...

Sen. Bill Cassidy (R-La.) said he secured significant concessions from the Trump administration on vaccine safety that led to ...

Shares of vaccine maker Moderna fell Wednesday as Goldman Sachs lowered its rating after the biotech’s second cut to product ...

Goldman Sachs downgraded the vaccine maker to Neutral from Buy and slashed its stock-price target to $51 from $99 Wednesday.

Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...

The first human bird flu death in the US has Moderna's vaccine development in focus for investors this week. Recently, Zacks.com users have been paying close attention to Novavax (NVAX).

He opened the hearing by declaring that he was deeply troubled by Mr. Kennedy’s “past of undermining confidence in vaccines.” By the end, he wondered aloud whether Mr. Kennedy, 71 ...

Moderna’s vaccine is designed to target H5 and H7 avian influenza viruses. HealthDay News — The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 ...

The US simplifies visa processing for US Green Card seekers, eliminating the need to return to their home country. (Reuters) US makes it simpler and easier for US Green Card seekers without having ...

GSK has filed a pair of lawsuits against Moderna, claiming infringement of patents covering mRNA vaccines for COVID-19 and respiratory syncytial virus (RSV). According to court documents ...